Intensive Review of Nephrology 2023

Nephrology CME: Comprehensive Clinical Update and Board Review

Intensive Review of Nephrology 2023 With over 90 sessions — including case-based lectures, Q&A discussions, board exam prep and test-taking skills — this online video CME program features nationally renowned speakers who provide a comprehensive and indispensable review of state-of-the-art nephrology.

+ Include: videos + pdf

publisher : oakstone

+ Information:

Intensive Review of Nephrology

Nephrology CME: Comprehensive Clinical Update and Board Review

With over 90 sessions — including case-based lectures, Q&A discussions, board exam prep and test-taking skills — this online video CME program features nationally renowned speakers who provide a comprehensive and indispensable review of state-of-the-art nephrology.

Intensive Review of Nephrology synthesizes recent advances in renal medicine, presenting them efficiently and effectively and ensuring you know the best ways to diagnose and treat your patients. You get valuable continuing medical education across all all major areas, with special insight on:

1. Genetic testing for improved prognosis and therapy selection
2. Introduction to point-of-care ultrasound: fundamentals for acquisition and interpretation
3. Physical exam of the dialysis access
4. Expanding the role of SGLT2i in diabetic and non-diabetic kidney disease
5. Cases in cryptonephrology
6. The new fundamentals in immunology and nephrology (it’s not just for transplant patients)
   and more…

Date of Original Release: September 30, 2023

Termination Date: January 31, 2026

Estimated Time to Complete the Activity: 51.75 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Patient Care and Procedural Skills
• Medical Knowledge
• Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Nephrology course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties

+ Topics:

1. Renal Physiology for the Boards – Melanie P. Hoenig, MD
2. Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
3. Question and Answer Session – Faculty
4. Renal Pathology in 2023 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD
5. Renal Pathology in 2023 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD
6. Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
7. Question and Answer Session – Faculty
8. Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD
9. Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
10. Social Determinants – Disparities in Renal Disease – Winfred W. Williams, Jr., MD
11. Question and Answer Session – Faculty
12. Update on Lupus Nephritis – Gerald B. Appel, MD
13. Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
14. Anemia Management – Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
15. Question and Answer Session – Faculty
16. Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
17. Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
18. Question and Answer Session – Faculty
19. Hyponatremia and Hypernatremia – David B. Mount, MD
20. Hypokalemia and Hyperkalemia – David B. Mount, MD
21. Question and Answer Session – Faculty
22. Important New Trials in Glomerular Disease – Saif Abdulkarim Muhsin, MB BCh
23. Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
24. Update on Polycystic Kidney Disease – Cristian Riella, MD
25. Pediatric Nephrology – Michael J.G. Somers, MD
26. Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
27. Rapidly Progressive Glomerulonephritis – John L. Niles, MD
28. Question and Answer Session – Faculty
29. Why Do We Reject a Transplant? – Jamil R. Azzi, MD
30. Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
31. Question and Answer Session – Faculty
32. Immunological Assessment Pre- and Post-Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
33. Early Post-Transplant Management – Anil K. Chandraker, MD
34. Question and Answer Session – Faculty
35. Donor Evaluation – Kassem Safa, MD
36. Late Loss of the Kidney Transplant – John Choi, MD
37. Infections in Transplant Recipients – Sarah P. Hammond, MD
38. Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD
39. Pre-Transplant Surgical Evaluation of Recipients – Saif Abdulkarim Muhsin, MB BCh
40. Question and Answer Session – Faculty
41. Poisonings and Intoxications – What a Nephrologist Needs to Know – Timothy B. Erickson, MD
42. Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
43. Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
44. Geriatric Nephrology – Ernest I. Mandel, MD
45. Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
46. Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD
47. Question and Answer Session – Faculty
48. Primary Aldosteronism – Anand Vaidya, MD, MMSc
49. Xenotransplantation – The ImPossible Solution – Jayme E. Locke, MD, MPH, FACS, FAST
50. Liver and the Kidney – Andrew S. Allegretti, MD, MSc
51. Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
52. Acute Kidney Injury Syndromes – Alice Sheridan, MD
53. ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
54. Question and Answer Session – Faculty
55. Acute Kidney Injury in Cancer – Raad Chowdhury, MD
56. Dysproteinemia and Kidney Disease – The Clone Wars – Raad Chowdhury, MD
57. Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2023 – Richard J. Glassock, MD
58. Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
59. APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
60. Question and Answer Session – Faculty
61. Patient Perspective – Dialysis Dosing – Moderators: J. Kevin Tucker, MD and Paul Moore, RN, Dialysis Patients: Daphne Bryant and Vanessa Evans
62. Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD
63. Question and Answer Session – Faculty
64. Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
65. Pearls in Mineral and Bone Disease – David Bushinsky, MD
66. Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh
67. Question and Answer Session – Faculty
68. Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
69. Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
70. Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD
71. Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD
72. Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
73. Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
74. Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
75. Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
76. Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
77. Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
78. Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP
79. COVID-19 Vaccination Response in Transplant Patients – Ann Woolley, MD
80. Update on Renovascular Disease – Joseph M. Garasic, MD
81. Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD
82. Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
83. Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
84. Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
85. Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
86. Pregnancy and Renal Disease – Jessica Tangren, MD
87. Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, MD
88. Transplant Board Review – Anil K. Chandraker, MD
89. Must-Know Board Zebras – Emily Robinson, MD, MPH
90. Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
91. Nephrology Board Review Practice 2 – Mallika Mendu, MD